SciTransfer
Organization

VERMON SA

French SME designing and manufacturing ultrasonic transducers for medical imaging, cancer diagnostics, smart catheters, and industrial non-destructive testing.

Technology SMEdigitalFRSMENo active H2020 projects
H2020 projects
5
As coordinator
1
Total EC funding
€2.4M
Unique partners
72
What they do

Their core work

VERMON is a French SME that designs and manufactures ultrasonic transducers and piezoelectric sensor systems. Their core technology — precision ultrasound probes — is applied across medical imaging (cancer diagnostics, intravascular ultrasound), industrial non-destructive testing, and miniaturized implantable devices. In H2020 projects, they consistently serve as the ultrasound hardware specialist, supplying custom transducer arrays and piezoelectric components to multi-partner consortia tackling biomedical and industrial sensing challenges.

Core expertise

What they specialise in

Ultrasonic transducer design and manufacturingprimary
5 projects

Ultrasonic/piezoelectric technology is the common thread across all five projects, from MEMS energy harvesting (smart-MEMPHIS) to medical diagnostics (LUCA, SOLUS) and NDT inspection (FrictionHarmonics).

Medical ultrasound for cancer diagnosticsprimary
3 projects

LUCA (thyroid nodule analysis), SOLUS (breast cancer diagnostics), and POSITION-II (intravascular ultrasound catheters) all involve biomedical ultrasound applications.

Smart catheters and implantable devicessecondary
2 projects

POSITION-II focused on next-generation smart catheters with IVUS/FFR/ICE capabilities, while smart-MEMPHIS developed miniaturized MEMS piezoelectric systems.

Non-destructive testing (NDT) and industrial inspectionsecondary
1 project

FrictionHarmonics — their only coordinated project — developed automated ultrasound scanning for detecting kissing bonds in friction stir welded materials.

MEMS piezoelectric energy harvestingemerging
1 project

smart-MEMPHIS explored MEMS piezo-based energy harvesting with integrated supercapacitors, extending their piezoelectric expertise beyond sensing into power generation.

Evolution & trajectory

How they've shifted over time

Early focus
Piezoelectric sensors and cancer diagnostics
Recent focus
Interventional devices and industrial NDT

VERMON's early H2020 work (2014-2016) centered on piezoelectric fundamentals — MEMS energy harvesting and first forays into combining ultrasound with optical diagnostics for cancer detection (thyroid nodules). By 2018, their focus shifted decisively toward interventional medical devices (smart catheters, IVUS, implantables) and industrial quality control (automated weld inspection). The trajectory shows a company moving from component-level R&D toward integrated, application-ready systems in both healthcare and manufacturing.

VERMON is moving from pure transducer components toward complete integrated sensing systems for minimally invasive medical procedures and automated industrial inspection.

Collaboration profile

How they like to work

Role: specialist_contributorReach: European16 countries collaborated

VERMON operates primarily as a specialist partner (4 of 5 projects as participant), contributing ultrasound hardware expertise to larger consortia. They coordinated one SME-focused Innovation Action (FrictionHarmonics), suggesting they can lead when the project aligns closely with their core product. With 72 unique partners across 16 countries, they maintain a wide and diverse network — typical of a component supplier whose technology plugs into many different application domains.

VERMON has collaborated with 72 distinct partners across 16 countries, forming an unusually broad network for an SME of their size. This wide reach reflects their role as a transducer supplier whose components are needed by medical device developers, research hospitals, and industrial integrators across Europe.

Why partner with them

What sets them apart

VERMON occupies a rare niche as an SME that both designs and manufactures custom ultrasonic transducers — most competitors are either large corporates (e.g., GE, Olympus) or pure research labs. Their ability to bridge medical and industrial ultrasound applications makes them a versatile partner: the same piezoelectric expertise that builds breast cancer probes also builds weld inspection scanners. For consortium builders, they bring production-ready hardware capability, not just prototypes.

Notable projects

Highlights from their portfolio

  • smart-MEMPHIS
    Largest single EC contribution (EUR 1,013,419) — a major investment in MEMS piezoelectric energy harvesting that anchored VERMON's early H2020 portfolio.
  • FrictionHarmonics
    Their only coordinated project, applying ultrasound expertise to an unexpected domain — automated kissing bond detection in friction stir welded materials.
  • SOLUS
    Combines ultrasound with optical diagnostics for non-invasive breast cancer screening, demonstrating VERMON's capacity to integrate into multi-modal sensing systems.
Cross-sector capabilities
Health & biomedical devicesManufacturing quality control & NDTEnergy harvesting & MEMSTransport & aerospace inspection
Analysis note: VERMON is a known ultrasonic transducer manufacturer (verifiable via their website), which provides strong context for interpreting the project data. The 5-project portfolio is moderately sized but highly coherent around piezoelectric/ultrasound technology, enabling a confident profile. Keywords for smart-MEMPHIS and FrictionHarmonics were not provided in the data, so those projects are characterized primarily from their titles.